AVROBIO Inc
Biotechnology
Healthcare
AVRO
44.28 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
1.39
52 week high
6.25
high
1.45
52 week low
1.32
low
1.38
growth
-15.29 %
previous Close
1.36
P/E ratio
market cap
67.04 M
div yield
0
usd
Jun 2023
qoq
revenue
0.00 %
net incoming
67.48 M
0.00 %
eps
0.00 %
35.09 %
eps surprise
-428.57 %
net profit margin
6747600000.00 %
0.00 %
operating incoming
68.01 M
369.66 %
net change in cash
52.76 M
360.73 %
cash on hand
125 M
0.00 %
cost of revenue
0.00 %
top top